This article highlights the congressional briefing, Reducing Overreliance on Psychotropics for Children and Youth in Foster Care, in which PolicyLab Co-Director Kathleen Noonan discussed an overview of the foster care population. …

PolicyLab's Kathleen Noonan is quoted discussing guidelines to reduce psychotropic medication use nationwide for children and foster youth.

PolicyLab's Amanda Kreider is interviewed about recent PolicyLab research that studied 1.3 American kids and found that certain antipsychotic medications raise their risk of Type 2 diabetes.

This article discusses recent findings from Dr. David Rubin and his research team that found children who take second-generation antipsychotics may face an increased risk for Type II diabetes.

This article discusses recent findings from Dr. David Rubin and his research team that found children who take second-generation antipsychotics may face an increased risk for Type II diabetes.

This article discusses recent research findings from Dr. David Rubin and his team that found antipsychotics raises the risk of developing Type II diabetes and their recommendations for going forward.

This article discusses recent findings from Dr. David Rubin and his research team that found children who take second-generation antipsychotics may face an increased risk for Type II diabetes.

This article discusses recent research findings from Dr. David Rubin and his team that found antipsychotics raises the risk of developing Type II diabetes by 50%; the article discusses recommendations for going forward.

This article discusses research findings from Dr. David Rubin that found initiating antipsychotics may increase a child's risk for for Type 2 diabetes by nearly 50%, and the risk may double if also taking antidepressants.

PolicyLab's Rachel Meadows and Dr. David Rubin are interviewed about their report that examined the effect of the Great Recession on child health and well-being.